Cell Therapy Process Development

The Cellerant Process Development team has extensive experience in developing processes for autologous and allogeneic cell therapy manufacturing. At a very early stage of the product development cycle, the manufacturing process is developed to be cGMP-compliant and scalable, and maximizes the use of disposable materials and closed-system operations. The team has extensive experience in scaling a wide variety of cell types in systems spanning from flasks to large cell culture bags and disposable bioreactors, and they are also skilled in large-scale closed-system cell harvesting technologies, cryo-formulation development, large-scale filling technologies and large-scale cellular cryopreservation. Cellerant also has a strong Assay Development team that develops and qualifies in-process and lot release assays to test for critical quality attributes.

 

Copyright ©2006-2016 Cellerant Therapeutics, Inc.